Literature DB >> 1591887

IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis.

A E Prada1, C F Strife.   

Abstract

The IgG subclass distribution for autoantibodies to solid-phase C1q (anti-spC1q) in sera from 14 patients with membranoproliferative glomerulonephritis (MPGN) and 10 patients with systemic lupus erythematosus (SLE) nephritis was determined by an enzyme-linked immunosorbant assay employing C1q as the immunosorbant in the presence of 2 M NaCl to prevent Fc binding and monoclonal anti-human IgG subclass reagents. The autoantibody to spC1q in MPGN, especially in types I (7 patients) and II (3 patients), was almost entirely restricted to IgG3. In contrast, in SLE anti-spC1q was completely restricted to IgG2 in 3 patients while predominantly IgG2 in the other 7 patients. The different subclass restriction of anti-spC1q in these two disorders suggests that antibody formation is either in response to different epitopes on the collagen-like region of C1q or that patients with SLE and MPGN mount different immunologic responses to the same antigenic stimulus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591887     DOI: 10.1016/0090-1229(92)90097-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  9 in total

Review 1.  Autoantibodies against C1q: view on clinical relevance and pathogenic role.

Authors:  C E Siegert; M D Kazatchkine; A Sjöholm; R Würzner; M Loos; M R Daha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

Review 3.  Are anti-C1q antibodies different from other SLE autoantibodies?

Authors:  Matthew C Pickering; Marina Botto
Journal:  Nat Rev Rheumatol       Date:  2010-04-27       Impact factor: 20.543

4.  Autoreactivity to mouse C1q in a murine model of SLE.

Authors:  P K Trinder; M J Maeurer; H U Schorlemmer; M Loos
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

5.  Serologic markers of lupus nephritis in patients: use of a tissue-based ELISA and evidence for immunopathogenic heterogeneity.

Authors:  K A Bernstein; L E Kahl; J E Balow; J B Lefkowith
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

6.  Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.

Authors:  J E Salmon; S Millard; L A Schachter; F C Arnett; E M Ginzler; M F Gourley; R Ramsey-Goldman; M G Peterson; R P Kimberly
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

Review 7.  Complement components and their autoantibodies.

Authors:  P Norsworthy; K A Davies
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.860

Review 8.  Autoantibodies against complement component C1q in systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Clin Transl Immunology       Date:  2021-04-29

9.  Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies.

Authors:  Juan Irure-Ventura; Marcos López-Hoyos
Journal:  J Transl Autoimmun       Date:  2022-01-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.